HB19-1216 limits the cost sharing of insulin for commercial pay patients to $100 for a 30 days’ supply, effective January1, 2020. The Department of Regulatory Agencies Division of Insurance issued emergency rules to address implementation. https://gallery.mailchimp.com/6431ea4066ae863439c487bd4/files/bd896d11-f54b-4f15-b31d-fd2c3ccad71d/Emergency_Regulation_19_E_08_Concerning_Prescription_Insulin_Drug_Cost_Sharing_and_Limitations.pdf
Also in Colorado… General Assembly convened on January 8th.
For more information, contact NACDS’ Mary Staples at 817-442-1155.